Wells Fargo & Company Forecasts Strong Price Appreciation for National Health Investors (NYSE:NHI) Stock

National Health Investors (NYSE:NHI) had its price target upped by equities researchers at Wells Fargo & Company from $80.00 to $85.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 6.81% from the stock’s previous close.

Other research analysts have also recently issued reports about the company. Cantor Fitzgerald began coverage on National Health Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target on the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Truist Financial boosted their target price on shares of National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Finally, National Bankshares set a $90.00 target price on shares of National Health Investors in a research note on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $85.67.

National Health Investors Price Performance

National Health Investors stock traded up $0.81 during mid-day trading on Tuesday, hitting $79.58. The stock had a trading volume of 46,170 shares, compared to its average volume of 234,212. National Health Investors has a one year low of $65.13 and a one year high of $80.56. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.79 billion, a P/E ratio of 25.42, a P/E/G ratio of 3.31 and a beta of 0.74. The firm’s 50 day moving average is $76.65 and its 200 day moving average is $74.51.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. The business had revenue of $83.36 million for the quarter, compared to analysts’ expectations of $85.66 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business’s quarterly revenue was down 1.8% on a year-over-year basis. During the same period last year, the firm earned $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, sell-side analysts forecast that National Health Investors will post 4.41 earnings per share for the current fiscal year.

Institutional Investors Weigh In On National Health Investors

Institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. lifted its holdings in shares of National Health Investors by 305.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after acquiring an additional 906,479 shares during the last quarter. Norges Bank purchased a new stake in shares of National Health Investors in the 2nd quarter worth $49,775,000. M Holdings Securities Inc. purchased a new stake in National Health Investors in the second quarter worth about $36,607,000. Balyasny Asset Management L.P. lifted its position in shares of National Health Investors by 66.9% in the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after purchasing an additional 246,486 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in National Health Investors by 481.3% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock valued at $18,792,000 after acquiring an additional 195,716 shares in the last quarter. 62.51% of the stock is owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.